Clinical Trial Update: Molecular Analysis and Treatment Options of SCLC

View source ↗

Summary

A clinical trial at Shanghai Chest Hospital is investigating molecular analysis and treatment options for small-cell lung cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Snippet

Sponsor: Shanghai Chest Hospital | Conditions: Small-cell Lung Cancer, Small Cell Lung Cancer, Combined Type | Status: RECRUITING